Chronic Rhinosinusitis (Diagnosis) Clinical Trial
Official title:
A Prospective Single-center Cohort Study of Surgical Treatment of Chronic Rhinosinusitis
Chronic Rhinosinusitis (CRS) is a common and frequent disease in otorhinolaryngology. The main symptoms of patients include nasal congestion, runny nose, swelling pain of the frontal area and decreased sense of smell. Chronic rhinosinusitis refers to chronic rhinosinusitis with symptoms lasting ≥12 weeks and can be divided into two subgroups: chronic rhinosinusitis with and without nasal polyps. Chronic rhinosinusitis has a complex pathogenesis, there are three main pathogenic factors: infection, allergy and nasal and sinus anatomic abnormalities, these factors are often not a single existence, but often intertwined. In addition, environmental factors, genetic factors, osteitis, gastroesophageal reflux disease, respiratory ciliary system defects, systemic immune dysfunction and other secondary risk factors. For patients with chronic sinusitis, these symptoms, such as nasal congestion, runny nose, swelling pain and decreased sense of smell, often seriously affect their quality of life, and even evolve into more serious complications as the disease progresses. At present, the conventional treatment methods mainly include drug conservative treatment and nasal endoscopic surgery. Functional nasal endoscopic sinus surgery (FESS) is the main method of further surgical treatment for patients with no obvious effect of drug treatment. In FESS, the current emphasis is on removing diseased tissue and restoring sinus drainage on the premise of preserving the normal mucosa and physiological structure of the nasal and nasal sinuses as much as possible. Up to now, there have been many studies on surgical treatment of CRS, and the quality of the studies varies. However, in view of the postoperative efficacy and long-term prognosis of different subtypes of CRS, different treatment methods during surgery and different drug therapy regimens, our research group believes that it is necessary to accumulate a large amount of clinical data support through in-depth research and comprehensive analysis. Thus more reliable conclusions can be drawn. In this study, patients undergoing CRS surgery in the research ward of the Department of rhinosinusitis will be actively included through a prospective single-center cohort study to provide evidence for evidence-based medicine and better guide clinical rhinologists to make surgical treatment decisions for patients with chronic rhinosinusitis.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05895929 -
The Role of IL5 in Epithelial Cell Integrity
|
Early Phase 1 | |
Completed |
NCT03673956 -
Topical Antibiotics in Chronic Rhinosinusitis
|
Phase 1/Phase 2 | |
Recruiting |
NCT03970655 -
Functional Endoscopic Sinus Surgery Study
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04514120 -
Alsaleh-Javer Endoscopic Sinus Score (AJESS) System
|
N/A | |
Recruiting |
NCT03963648 -
NO Measurements in Screening for Asthma and OSA, in Patients With CRSwNP
|
N/A | |
Recruiting |
NCT05009758 -
Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps
|
N/A | |
Active, not recruiting |
NCT05553951 -
Adherence in Global Airways
|
N/A | |
Completed |
NCT03563521 -
Identifying Serum Cytokine Profiles of Distinct Inflammatory Phenotypes in Severe Asthma
|
||
Completed |
NCT05035654 -
LYR-220 for Adult Subjects With Chronic Rhinosinusitis (BEACON Study)
|
Phase 2 | |
Withdrawn |
NCT03369574 -
Study of Chronic Rhinosinusitis Symptoms in Asthma Patients Undergoing Treatment With Reslizumab
|
||
Recruiting |
NCT05400616 -
Nasal Microbiota Transfer Therapy in Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
|
N/A | |
Recruiting |
NCT04628442 -
Tissue Immune Interaction in Nasal Polyposis
|
||
Completed |
NCT04041609 -
LYR-210 Depot (LYR-210) for Adult Subjects With Chronic Sinusitis (LANTERN Study)
|
Phase 2 | |
Completed |
NCT04048070 -
The Effect of Enhanced Recovery After Surgery in Endoscopic Sinus Surgery
|
N/A | |
Recruiting |
NCT03439865 -
Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis
|
Early Phase 1 | |
Recruiting |
NCT05857228 -
Viral and Epigenetic Influences in CRSwNP
|
||
Completed |
NCT03122795 -
Sinonasal Microbiome Transplant as a Therapy for Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
|
N/A | |
Recruiting |
NCT05295459 -
Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults (ENLIGHTEN 2)
|
Phase 3 | |
Completed |
NCT04858802 -
A Clinical Evaluation of PROPEL® Contour Sinus Implant
|
N/A | |
Completed |
NCT04572516 -
Botulium Toxin Type A In Non Infectious Chronic Rhinosinusitis
|
Phase 3 |